Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
7.54
+0.13 (1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed

Adverum Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
15776581731,057744
Upgrade
Market Cap Growth
-10.96%31.60%-66.54%-83.65%42.01%275.72%
Upgrade
Enterprise Value
5734-40-38633609
Upgrade
Last Close Price
7.547.535.7917.60108.40115.20
Upgrade
PE Ratio
--0.65-0.37-1.19-7.85-11.45
Upgrade
PS Ratio
128.8321.13-23.03-2976.22
Upgrade
PB Ratio
1.090.910.320.552.434.25
Upgrade
P/FCF Ratio
-1.60-0.83-0.48-1.40-11.59-10.88
Upgrade
P/OCF Ratio
-1.61-0.84-0.53-1.60-13.33-15.13
Upgrade
EV/Sales Ratio
56.909.58--5.01-2437.97
Upgrade
EV/EBITDA Ratio
-0.23-0.290.280.27-5.57-9.10
Upgrade
EV/EBIT Ratio
-0.22-0.280.260.26-5.37-8.89
Upgrade
EV/FCF Ratio
-0.26-0.380.330.31-6.95-8.91
Upgrade
Debt / Equity Ratio
0.440.900.590.330.070.18
Upgrade
Debt / FCF Ratio
-0.83-0.82-0.89-0.84-0.34-0.47
Upgrade
Asset Turnover
-0.01-0.02-0.00
Upgrade
Quick Ratio
7.743.875.7614.5820.598.55
Upgrade
Current Ratio
7.994.135.9114.8820.829.06
Upgrade
Return on Equity (ROE)
-66.76%-88.43%-62.10%-38.78%-38.57%-34.29%
Upgrade
Return on Assets (ROA)
-27.31%-32.14%-25.12%-19.66%-20.90%-19.64%
Upgrade
Return on Capital (ROIC)
-29.13%-34.62%-26.56%-20.51%-21.93%-20.96%
Upgrade
Earnings Yield
-60.00%-154.06%-267.40%-84.25%-11.12%-8.67%
Upgrade
FCF Yield
-56.82%-120.59%-207.48%-71.18%-8.62%-9.20%
Upgrade
Buyback Yield / Dilution
-43.94%-1.58%-1.24%-15.14%-32.83%-4.44%
Upgrade
Total Shareholder Return
-43.94%-1.58%-1.24%-15.14%-32.83%-4.44%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.